100 related articles for article (PubMed ID: 2119106)
1. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging.
Fretz CJ; Stark DD; Metz CE; Elizondo G; Weissleder R; Shen JH; Wittenberg J; Simeone J; Ferrucci JT
AJR Am J Roentgenol; 1990 Oct; 155(4):763-70. PubMed ID: 2119106
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
[TBL] [Abstract][Full Text] [Related]
3. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
Kim MJ; Kim JH; Chung JJ; Park MS; Lim JS; Oh YT
Radiology; 2003 Sep; 228(3):719-26. PubMed ID: 12881583
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide.
Vidiri A; Carpanese L; Annibale MD; Caterino M; Cosimelli M; Zeuli M; David V; Crecco M
J Exp Clin Cancer Res; 2004 Mar; 23(1):53-60. PubMed ID: 15149151
[TBL] [Abstract][Full Text] [Related]
5. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography.
Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM
Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932
[TBL] [Abstract][Full Text] [Related]
6. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis.
Ward J; Chen F; Guthrie JA; Wilson D; Lodge JP; Wyatt JI; Robinson PJ
Radiology; 2000 Jan; 214(1):159-66. PubMed ID: 10644117
[TBL] [Abstract][Full Text] [Related]
7. Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases: a receiver operating characteristic analysis.
Rummeny EJ; Wernecke K; Saini S; Vassallo P; Wiesmann W; Oestmann JW; Kivelitz D; Reers B; Reiser MF; Peters PE
Radiology; 1992 Mar; 182(3):879-86. PubMed ID: 1535912
[TBL] [Abstract][Full Text] [Related]
8. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences.
Ward J; Guthrie JA; Wilson D; Arnold P; Lodge JP; Toogood GJ; Wyatt JI; Robinson PJ
Radiology; 2003 Sep; 228(3):709-18. PubMed ID: 12888620
[TBL] [Abstract][Full Text] [Related]
9. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
10. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T.
Marchal G; Van Hecke P; Demaerel P; Decrop E; Kennis C; Baert AL; van der Schueren E
AJR Am J Roentgenol; 1989 Apr; 152(4):771-5. PubMed ID: 2784260
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of computerized tomography and magnetic resonance with fast sequences with and without paramagnetic contrast media in the assessment of liver metastasis: qualitative and quantitative analysis].
Maccioni F; Broglia L; Rossi P
Radiol Med; 1997 Jun; 93(6):708-14. PubMed ID: 9411518
[TBL] [Abstract][Full Text] [Related]
12. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.
Pirovano G; Vanzulli A; Marti-Bonmati L; Grazioli L; Manfredi R; Greco A; Holzknecht N; Daldrup-Link HE; Rummeny E; Hamm B; Arneson V; Imperatori L; Kirchin MA; Spinazzi A
AJR Am J Roentgenol; 2000 Oct; 175(4):1111-20. PubMed ID: 11000175
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
15. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging.
Ward J; Robinson PJ; Guthrie JA; Downing S; Wilson D; Lodge JP; Prasad KR; Toogood GJ; Wyatt JI
Radiology; 2005 Oct; 237(1):170-80. PubMed ID: 16126930
[TBL] [Abstract][Full Text] [Related]
16. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography.
Rappeport ED; Loft A
Abdom Imaging; 2007; 32(5):624-34. PubMed ID: 17710359
[TBL] [Abstract][Full Text] [Related]
17. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT.
Sofue K; Tateishi U; Tsurusaki M; Arai Y; Yamazaki N; Sugimura K
Eur J Radiol; 2012 Apr; 81(4):714-8. PubMed ID: 21353412
[TBL] [Abstract][Full Text] [Related]
19. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
Helmberger T; Gregor M; Holzknecht N; Rau H; Scheidler J; Reiser M
Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
[TBL] [Abstract][Full Text] [Related]
20. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
